XML 16 R6.htm IDEA: XBRL DOCUMENT v3.21.1
INTERIM CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Series A Preferred Stock
Series B Preferred Stock
Total stockholders' equity
Total stockholders' equity
Series A Preferred Stock
Total stockholders' equity
Series B Preferred Stock
Preferred Stock
Common stock
Additional paid-in capital
Accumulated other comprehensive income (loss)
Accumulated dividends in excess of earnings
Accumulated dividends in excess of earnings
Series A Preferred Stock
Accumulated dividends in excess of earnings
Series B Preferred Stock
Noncontrolling interests
Beginning balance (in shares) at Dec. 31, 2019             7,443 58,228            
Beginning balance at Dec. 31, 2019 $ 1,444,451     $ 1,337,817     $ 407,435 $ 582 $ 1,330,444 $ (24,642) $ (376,002)     $ 106,634
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net share activity through equity award plan (in shares)               240            
Net share activity through equity award plan (1,458)     (1,309)       $ 3 (1,312)         (149)
Increase (decrease) in fair value of derivative contracts (36,715)     (33,155)           (33,155)       (3,560)
Foreign currency translation adjustments (223)     (201)           (201)       (22)
Equity-based compensation expense 4,875     4,377         4,377         498
Proceeds net of fees from settlement of forward shares (in shares)               1,930            
Proceeds net of fees from settlement of forward shares 83,217     78,535       $ 19 78,516         4,682
Dividends declared on Preferred Stock (7,045) $ (1,906) $ (5,139)   $ (1,906) $ (5,139)           $ (1,906) $ (5,139)  
Dividends declared to common stockholders (28,393)     (28,393)             (28,393)      
Dividends declared to noncontrolling interests (3,133)     0                   (3,133)
Net income 8,120     8,010             8,010     110
Ending balance (in shares) at Mar. 31, 2020             7,443 60,398            
Ending balance at Mar. 31, 2020 1,463,696     1,358,636     $ 407,435 $ 604 1,412,025 (57,998) (403,430)     105,060
Beginning balance (in shares) at Dec. 31, 2020             7,443 64,580            
Beginning balance at Dec. 31, 2020 1,584,698     1,476,174     $ 407,435 $ 646 1,622,857 (50,451) (504,313)     108,524
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net share activity through equity award plan (in shares)               426            
Net share activity through equity award plan 59     54       $ 4 50         5
Conversion of Class A Partnership units to Class A common stock (in shares)               92            
Conversion of Class A Partnership units to Class A common stock 0     2,041       $ 1 2,040         (2,041)
Increase (decrease) in fair value of derivative contracts 17,253     15,414           15,414       1,839
Foreign currency translation adjustments (158)     (144)           (144)       (14)
Equity-based compensation expense 6,856     6,237         6,237         619
Proceeds net of fees from settlement of forward shares (in shares)               3,865            
Proceeds net of fees from settlement of forward shares 215,846     203,164       $ 39 203,125         12,682
Dividends declared on Preferred Stock (7,045) $ (1,906) $ (5,139)   $ (1,906) $ (5,139)           $ (1,906) $ (5,139)  
Dividends declared to common stockholders (32,512)     (32,512)             (32,512)      
Dividends declared to noncontrolling interests (3,235)     0                   (3,235)
Net income 7,918     7,839             7,839     79
Ending balance (in shares) at Mar. 31, 2021             7,443 68,963            
Ending balance at Mar. 31, 2021 $ 1,789,680     $ 1,671,222     $ 407,435 $ 690 $ 1,834,309 $ (35,181) $ (536,031)     $ 118,458